Literature DB >> 13749074

Results of a French survey on the role of tobacco, particularly inhalation, in different cancer sites.

D SCHWARTZ, R FLAMANT, J LELLOUCH, P F DENOIX.   

Abstract

Entities:  

Keywords:  NEOPLASMS/etiology; SMOKING

Mesh:

Year:  1961        PMID: 13749074

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  20 in total

1.  THE RELATIONSHIP OF BLADDER CANCER TO SMOKING.

Authors:  A M LILIENFELD
Journal:  Am J Public Health Nations Health       Date:  1964-11

2.  MORTALITY IN RELATION TO SMOKING: TEN YEARS' OBSERVATIONS OF BRITISH DOCTORS.

Authors:  R DOLL; A B HILL
Journal:  Br Med J       Date:  1964-06-06

3.  SMOKING AND CANCER OF THE BLADDER.

Authors:  F L RAFFUCCI
Journal:  Br Med J       Date:  1965-09-18

4.  A case-control study of risk factor for renal cell cancer in northern Italy.

Authors:  R Talamini; A E Barón; S Barra; E Bidoli; C La Vecchia; E Negri; D Serraino; S Franceschi
Journal:  Cancer Causes Control       Date:  1990-09       Impact factor: 2.506

5.  Occupation, smoking, and alcohol in the epidemiology of bladder cancer.

Authors:  R C Brownson; J C Chang; J R Davis
Journal:  Am J Public Health       Date:  1987-10       Impact factor: 9.308

6.  Bladder cancer and smoking.

Authors: 
Journal:  Br Med J       Date:  1972-03-25

7.  Smoking, sputum, and lung cancer.

Authors:  J Rimington
Journal:  Br Med J       Date:  1968-03-23

8.  Are smokers' self-reports of inhalation a useful measure of smoke exposure.

Authors:  R Stepney
Journal:  J Epidemiol Community Health       Date:  1982-06       Impact factor: 3.710

9.  Reducing aluminum: an occupation possibly associated with bladder cancer.

Authors:  G Thériault; L De Guire; S Cordier
Journal:  Can Med Assoc J       Date:  1981-02-15       Impact factor: 8.262

10.  Mortality from cancer of the head and neck, lung and esophagus in eastern Austria between 1960 and 1989.

Authors:  H Swoboda; H P Friedl
Journal:  Eur Arch Otorhinolaryngol       Date:  1994       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.